Dear Friends of LRF,

The Lymphoma Research Foundation (LRF) is defined by its tireless
commitment to our mission: eradicating lymphoma and serving those
who have been touched by this disease. With each breakthrough, we are
one step closer to reaching these goals.

In this issue of Pulse, we profile one of the innovative leaders responsible for such breakthroughs, Laura Pasqualucci, MD, Professor of Pathology and Cell Biology at the Institute for Cancer Genetics at Columbia University and a member of the Foundation’s prestigious Scientific Advisory Board (SAB). Dr. Pasqualucci’s interest in medicine began during her childhood in Italy, watching her father work as a physician. Now, she is creating a brighter road ahead for patients and researchers alike through her groundbreaking work studying lymphoma mutations and through her leadership as a mentor in LRF’s Lymphoma Scientific Research Mentoring Program (LSRMP).

You’ll also read about Tatiana, whose world was turned upside down when her mother, Paulette, was diagnosed with adult T-cell lymphoma at age 48. As she cared for her mother through chemotherapy, radiation, and immunotherapy, she struggled to find stories of cancer patients and caregivers that she could relate to as a woman of color. Out of this struggle she founded Chemo Divas, a nonprofit foundation dedicated to sharing the experiences of women of color who’ve been diagnosed with cancer and improving health equity by providing resources and financial support to this historically underserved community.

Lastly, you will read about the Foundation’s impact at the 2023 American Society of Hematology Annual Meeting & Exposition. Over 300 LRF-affiliated scientists contributed to an abstract presented at this year’s conference, the world’s premier event in hematology. Their findings and discoveries will be critical to developing new treatments and deepened understanding of lymphomas across the entire spectrum of subtypes and patient populations.

We are profoundly grateful for your unwavering commitment to LRF’s mission. Your support, together with the expert leadership of our Scientific Advisory Board and the dedication of our researchers, brings us closer and closer each day to our shared vision: a world without lymphoma.